On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes.

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...